NVIDIA Below Max Pain as Options Market Prices AI Leadership Premium
Monday 18 May 2026 | Stocks | NVDA
Session Summary
NVIDIA closed Monday at $222.32, sitting approximately 1.2% below its options max pain level of $225 for the Friday 18 May weekly expiry. The options market shows call volume of 1.41 million contracts versus 688,573 puts — a put-to-call ratio of 0.49 which is heavily skewed toward bullish positioning. Despite this bullish options skew, NVIDIA underperformed relative to the call positioning, suggesting that the upside momentum expected by options buyers has not yet materialised this session. NVIDIA appears on the broad institutional bullish options list for Monday alongside META, MSFT, AAPL, and AMZN.
Daily Read
NVIDIA’s position as the dominant AI infrastructure supplier means its price action is as much about narrative as it is about fundamentals in the short term. The Nasdaq closed down 0.43% on the day, and within that context NVIDIA’s position below its max pain level at $222 is instructive. Max pain theory suggests that options market makers benefit from price gravitating toward the level where the maximum number of options contracts expire worthless — at $225. With NVIDIA trading $2.68 below that, there is a mechanical argument for price to drift higher through expiry.
The broader AI spending cycle remains the structural bull case. With VIX at 17.82 and declining (down 3.31% today), the fear premium is being priced out of equities, which historically benefits the high-growth names. The AAII survey showing bulls at 39.3% — above historical averages for the fourth consecutive week — means retail sentiment is constructive without being euphoric, which is the ideal backdrop for continued AI positioning. The put-to-call ratio of 0.49 at NVIDIA confirms that institutional options traders are positioned for further upside rather than hedging against a fall.
Key Levels
| Level | Price | Context |
|---|---|---|
| Max Pain / Resistance | $225.00 | Options max pain for Friday 18 May expiry; price is magnetically drawn here by market mechanics |
| Extended Resistance | $230.00 | Round-number level above max pain; breakout target if momentum builds |
| Entry (long) | $220.00 — $222.00 | Current price zone; buy the dip into max pain mechanics with a tight stop |
| Stop | $216.00 | Below a meaningful technical support; failure here signals the max pain gravity is not working |
| Target | $225.00 — $228.00 | Max pain through to the breakout extension; R:R approximately 1.5:1 to 2:1 |
Tomorrow’s Setup
Bias: Moderately bullish, with max pain mechanics providing a near-term upward pull. The combination of institutional bullish options positioning and the $225 max pain magnet creates a constructive set-up for Tuesday.
- Bull scenario: QQQ stabilises and opens higher Tuesday. NVDA follows, reclaims $225 and closes above it. Volume confirmation above $225 opens a run to $230.
- Bear scenario: Tech sells off further as bond yields rise. NVDA breaks below $218 — $216, invalidating the max pain thesis. That is a 2.4% drop from current levels and would require a significant macro catalyst.
- Earnings watch: NVDA is not reporting this week, so the price action will be driven by sector flows and macro rather than company-specific news.
Experience Guidance
New to NVDA trading: Max pain is a short-term mechanical concept tied to options expiry — it tells you where the market wants to settle, not where it must go, so use it as a guide not a guarantee.
Developing trader: NVDA’s call-heavy options book (0.49 put-to-call) tells you institutional traders are positioned for higher prices — in the absence of a major negative catalyst, fighting that positioning is a low-probability trade.
Experienced trader: The $220 — $225 range is a clean defined-risk setup: long at $222, stop $216, target $228. The risk is $6 for a $6 gain at T1 — not exceptional, but the max pain mechanics and institutional positioning tilt the probability in favour of the long side.
This content is for informational and educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. All trading involves risk. Always conduct your own research before making any investment decisions.